A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)

Phase 2

Completed

• Conditions: Obesity

• Registration Number: NCT00533598
• Lead Sponsor: Merck Sharp & Dohme LLC

Brief Summary

The purpose of this study is to assess the effects of MK0557 on body weight in obese subjects.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Study Start: 2002-09
• Primary Completion: 2003-06
• Study Completion: 2003-06
• Study First Submitted: 2007-09-19
• Study First Submitted QC: 2007-09-20
• Study First Posted: 2007-09-21
• Status Verified: 2016-09
• Last Update Submitted: 2016-09-06
• Last Update Posted: 2016-09-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Men and women between 21 and 65 years of age, willing to avoid all prescription and nonprescription medicine to alter body weight for entire study

Read More

Exclusion Criteria

• You are or plan to become pregnant
• You have smoked or used nicotine within 6 months of the study
• History of abusing alcohol and/or drugs
• History of a stroke, you have diabetes mellitus, you are taking medication for high blood pressure, you have had recent surgery, you have been involved in another study within 3 months of study, use of cholesterol or anti-seizure medication during the study
• Have participated in a weight loss program 3 months before the study or during the course of the study

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL